ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation (2011)
- Authors:
- USP affiliated authors: PASINI, FÁTIMA SOLANGE - FM ; FERRAZ, ALBERTO ROSSETTI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- DOI: 10.1200/jco.2010.28.15_suppl.5540
- Subjects: POLIMORFISMO; MARCADOR MOLECULAR; PROGNÓSTICO; NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA); CARCINOMA DE CÉLULAS ESCAMOSAS (CIRURGIA); QUIMIOTERAPIA ADJUVANTE; ANTINEOPLÁSICOS (TOXICIDADE)
- Language: Inglês
- Imprenta:
- Source:
- Título: Oncology reports
- ISSN: 1021-335X
- Volume/Número/Paginação/Ano: v. 25, n. 3, p. 693-699, 2011
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
CASTRO, Gilberto de et al. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology reports, v. 25, n. 3, p. 693-699, 2011Tradução . . Disponível em: https://doi.org/10.1200/jco.2010.28.15_suppl.5540. Acesso em: 08 abr. 2026. -
APA
Castro, G. de, Pasini, F. S., Siqueira, S. A. C., Ferraz, A. R., Villar, R. C., Snitcovsky, I. M. L., & Federico, M. H. H. (2011). ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology reports, 25( 3), 693-699. doi:10.1200/jco.2010.28.15_suppl.5540 -
NLM
Castro G de, Pasini FS, Siqueira SAC, Ferraz AR, Villar RC, Snitcovsky IML, Federico MHH. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation [Internet]. Oncology reports. 2011 ; 25( 3): 693-699.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1200/jco.2010.28.15_suppl.5540 -
Vancouver
Castro G de, Pasini FS, Siqueira SAC, Ferraz AR, Villar RC, Snitcovsky IML, Federico MHH. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation [Internet]. Oncology reports. 2011 ; 25( 3): 693-699.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1200/jco.2010.28.15_suppl.5540 - ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT)
- Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients
- Determination of plasma osteopontin levels in patients with head and neck squamous cell carcinoma
- Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT)
- Avaliação prospectiva de polimorfismo genéticos da glutationa-s-transferase P1 como fator prognóstico e preditivo de resposta em pacientes portadores de carcinoma epidermóide de cabeça e pescoço tratados com quimiorradioterapia
- New possible predictive marker of survival in oral squamous cell carcinoma
- Gene expression pattern of primary oral cancer is predictive of cervical lymph node metastases
- Expression of CXCR1 and 'CX IND. 3'CR1 mRNA seems to outocome of the larynx squamous cell carcinoma
- HMGCR MRNA expression in tongue squamous cell carcinoma
- Detection of BRCA1 and BRCA2 germline mutations in brazilian breast cancer patients selected by Frank, Brcapro and Evans algorithms
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
